LINKÖPING, Sweden, March 27, 2024 /PRNewswire/ — SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States. SyntheticMR is proud to announce that its next-generation…
SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D
This post was originally published on this site